The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 53 | — | 20.1x | Near average | |
Growth | 1 | — | 5.6% | Below average | |
Quality | 15 | -53.8% | 7.6% | Below average | |
Safety | 66 | 2.5x | 0.4x | Near average | |
Capital Return | 39 | 0.00% | 2.19% | Near average | |
Momentum | 82 | — | — | Above average | |
Sentiment | 32 | — | — | Below average |
MapLight Therapeutics, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy MapLight Therapeutics, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
MPLT stock has witnessed a notable shift in analyst optimism over the past 30 days, with the average target price jumping by 38.7% to reach $43, supported by a series of new 'Buy' ratings from major institutions such as UBS and Craig-Hallum. However, the last week recorded a slight correction in the consensus by 5.14%, indicating a recalibration of expectations after the initial sharp rise, while the lowest target price ($36) remains significantly higher than the current market price.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.